Management of Type 2 Diabetes with Glipizide

Insulin Adjustment and Hypoglycemia Risk

When adding glipizide to an insulin regimen, consider reducing the insulin dose to prevent hypoglycemia, with a recommended reduction of approximately 20% for patients taking prandial insulin, according to the American College of Cardiology 1
The combination of sulfonylureas like glipizide with insulin significantly increases hypoglycemia risk, as noted by the American College of Cardiology and the American Diabetes Association 1, 2
Patients should be educated on recognizing and treating hypoglycemia, which can be reversed with rapid-acting glucose, as recommended by the American Diabetes Association 2

Monitor blood glucose levels closely during the first 3-4 weeks after initiating glipizide, with particular attention to fasting and pre-meal values, according to the American College of Cardiology 1
Regular monitoring of HbA1c every 3-6 months is necessary to assess the effectiveness of the regimen, as recommended by the American Diabetes Association 2

The combination of metformin, basal insulin, and a sulfonylurea addresses multiple pathophysiological defects in type 2 diabetes, according to the American Diabetes Association 4, 6
Consider SGLT2 inhibitors or GLP-1 receptor agonists as alternative add-on therapies if cardiovascular risk reduction is a priority, as recommended by the American College of Cardiology and the American Diabetes Association 7, 8